norgestimate has been researched along with Myocardial Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jick, H; Jick, SS | 1 |
| Cole, JA; Doherty, M; Norman, H; Walker, AM | 1 |
| Schwingl, PJ; Shelton, J | 1 |
3 other study(ies) available for norgestimate and Myocardial Infarction
| Article | Year |
|---|---|
The contraceptive patch in relation to ischemic stroke and acute myocardial infarction.
Topics: Administration, Topical; Adolescent; Adult; Brain Ischemia; Contraceptive Agents; Contraceptives, Oral; Female; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Retrospective Studies; Stroke | 2007 |
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Topics: Administration, Cutaneous; Brain Ischemia; Case-Control Studies; Cohort Studies; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Myocardial Infarction; Norgestrel; Stroke; Thromboembolism; Venous Thrombosis | 2007 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |